Digital Ophthalmic Technology Company Eyenovia has announced that it has signed a $50 million private equity investment (PIPE) agreement with institutional investors.
With this funding, the company plans to buy hype, a native token of the high lipid blockchain, create a cryptocurrency reserve and rename the company to “Hyperion Defi.” The new ticker symbol will be “Hypd”.
Einovia has also appointed Hyun Soo Jung as Chief Investment Officer (CIO) and a board member to serve as a board member.
According to a press release from the company, the $50 million investment will provide investors with unvoted preferred stock, converting it to about 15.4 million shares at $3.25 per share, offering about 30 million shares at the same price (warrant). If the warrant is fully exercised, Ainovia’s total revenue could reach $150 million.
“We are pleased to be one of the companies that adopted this strategy to assess the potential for cryptocurrency diversification, liquidity and long-term capital appreciation. After considering all the alternatives, we decided that this step was the greatest benefit of shareholders.”
“We are honored to lead this pioneering cryptocurrency strategy built around hype. We believe high lipids are one of the fastest growing and most profitable blockchains in the world,” the new Chief Investment Officer said.
With this agreement, Eyenovia aims to become one of the most active validators in high lipid networks around the world by purchasing more than one million hype tokens. Additionally, the staking program will begin in collaboration with Anchorage Digital.
*This is not investment advice.
